Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 516,141 | 158,837 | 278,738 | 130,763 | 79,529 |
| Marketable Securities | 112,980 | 88,240 | N/A | N/A | N/A |
| Receivables | 15,331 | 14,382 | 14,398 | 2,404 | 1,684 |
| Inventories | N/A | N/A | 6,848 | 7,058 | 7,055 |
| Other current assets | 0 | 17,140 | 0 | 0 | 0 |
| TOTAL | $649,861 | $281,280 | $303,701 | $143,598 | $92,337 |
| Non-Current Assets | |||||
| PPE Net | 29,507 | 30,131 | 39,425 | 40,997 | 42,512 |
| Investments And Advances | 0 | 24,242 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 1,551 | 1,880 | 2,103 |
| Other Non-Current Assets | 6,100 | 3,622 | 3,144 | 2,890 | 2,808 |
| TOTAL | $35,607 | $57,995 | $44,120 | $45,767 | $47,423 |
| Total Assets | $685,468 | $339,275 | $347,821 | $189,365 | $139,760 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,111 | 7,916 | 7,889 | 5,816 | 8,579 |
| Accrued Expenses | 28,817 | 31,706 | 28,898 | 4,097 | 4,429 |
| Other current liabilities | N/A | 27,595 | N/A | N/A | N/A |
| TOTAL | $42,527 | $72,327 | $68,740 | $44,698 | $49,840 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 800 | 1,110 | 27,991 | 30,975 | 33,170 |
| Other Non-Current Liabilities | 1,002 | 1,260 | 1,288 | 1,203 | 1,253 |
| TOTAL | $58,806 | $59,804 | $60,960 | $62,144 | $63,264 |
| Total Liabilities | $101,333 | $132,131 | $129,700 | $106,842 | $113,104 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,234 | 39,402 | 39,263 | 39,220 | 31,744 |
| Common Shares | 5 | 4 | 4 | 3 | 24 |
| Retained earnings | -1,503,116 | -1,490,187 | -1,476,502 | -1,444,149 | -1,420,832 |
| Other shareholders' equity | -241 | -1,216 | -1,378 | -637 | -2,248 |
| TOTAL | $584,135 | $207,144 | $218,121 | $82,523 | $26,656 |
| Total Liabilities And Equity | $685,468 | $339,275 | $347,821 | $189,365 | $139,760 |